share_log

Cannabis Company Launches Veterans Aid: $5K Grants For Housing Relief In Key Markets

大麻関連株会社が退役軍人支援を開始:主要市場での住宅支援のための0.5万ドルの助成金

Benzinga ·  2024/11/01 00:13

Multi-state marijuana operator MariMed (OTCQX:MRMD) announced the launch of a philanthropic initiative called Help on the Homefront. Set to start in November, this program was created to raise awareness about the housing challenges faced by veterans across the country.

MariMed's value-focused line of flower, vapes and gummies, InHouse, leads the initiative, aiming to offset the financial burden of monthly housing expenses or essential home improvements. Through Help on the Homefront, InHouse will provide $5,000 to a veteran in several of its retail markets, including Maryland, Massachusetts, Delaware and Illinois.

Read Also: 17 US Veterans Take Their Own Lives Everyday, Here's How One Cannabis Company Is Trying To Help

Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. If you're serious about the business, you can't afford to miss out.

"Help on the Homefront was created to recognize the many sacrifices that veterans have made on behalf of our country and offer meaningful financial relief to those facing housing-related difficulties," stated Olya Key, brand director for InHouse at MariMed. "We hope this program can provide some support to veterans in our communities as a small way of giving back."

Beginning November 1, eligible veterans aged 21+ may enter to win online. Friends and family are also welcome to submit an entry on behalf of a veteran. No purchase is necessary to participate and winners will be randomly selected and announced after the program ends on Nov. 30.

Price Action

MariMed shares closed Wednesday market session 1.25% higher at $0.16 per share.

  • EXCLUSIVE: Emotional Connection With Consumers Is Secret Sauce For Any Brand To Prosper, It's Same With Cannabis, Experts Say

Photo: Courtesy of RDNE Stock project via Pexels

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする